This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at http://www.elsevier.com/locate/withdrawalpolicy.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687018 | PMC |
| http://dx.doi.org/10.1016/j.bbrc.2013.02.026 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Perioperative methadone compared to placebo in elderly hip fracture patients: a study protocol for a randomized controlled trial (MetaHip trial).
Trials
December 2024
Department of Orthopedics, University Hospital of Southern Denmark, Kresten Philipsensvej 15, Aabenraa, 6200, Denmark.
Background: Hip fractures are a source of severe pain among the elderly population and pose challenges due to limited analgesic tolerance. Perioperative methadone has shown promise in our pilot study suggesting a safe dose of 0.10 mg/kg, prompting further investigation into its benefits for elderly hip fracture patients.
View Article and Find Full Text PDFWhy and when could nucleos(t)ide analogues treatment be withdrawn?
Dig Liver Dis
October 2024
Liver Unit and Laboratory of Molecular Genetics and Pathology of Hepatitis Viruses of Pisa University Hospital; Department of Clinical and Experimental Medicine, University of Pisa, Italy; Institute of Biostructure and Bioimaging, National Research Council, Naples, Italy. Electronic address:
Article Synopsis
- - Oral antiviral therapy with nucleos(t)ide analogues (NUCs) effectively reduces hepatitis B virus (HBV) levels, but achieving a functional cure (clearance of HBsAg) is uncommon.
- - While stopping NUC treatment can lead to HBsAg loss in 10% to 20% of patients, there's a high risk of virological relapse (50% to 80%) and the need for retreatment (40% to 55%).
- - Research is ongoing into using viral and immune biomarkers for better patient management post-treatment, along with AI-driven strategies for tailored NUC therapy decisions.
Damage-Induced Senescent Immune Cells Regulate Regeneration of the Zebrafish Retina.
Aging Biol
February 2024
Department of Biological Sciences, Vanderbilt University, Nashville, TN, USA.
Article Synopsis
- Zebrafish have the ability to regenerate their retinas after damage, driven by Müller glia (MG) cells.
- In higher vertebrates, similar MG do not promote retina regeneration, highlighting a loss of this ability.
- A study found that senescent cells, which are usually linked to aging, also play a role in retinal repair by influencing inflammation and regeneration processes during damage recovery.
Concise review of end of life and palliative care in neuromuscular pathologies: still a long pathway ahead.
Acta Myol
June 2024
Dipartimento di Biomedicina Traslazionale e Neuroscienze, UO di Malattie dell'Apparato Respiratorio, Azienda Ospedaliera Universitaria Consorziale, Policlinico di Bari, Italy.
Introduction: Neuromuscular diseases (NMD) include different types of diseases depending on the deficient component of the motor unit involved. They may all be interested by a progressive and sometimes irreversible pump respiratory failure which unfortunately for some NMD may start soon after the diagnosis. Within this vast group of patients those affected by muscle diseases are a subgroup who comprises patients with an average earlier onset of symptoms compared to other NMD.
View Article and Find Full Text PDFShort-Term Effects of Two COX-2 Selective Non-Steroidal Anti-Inflammatory Drugs on the Release of Growth Factors and Cytokines from Canine Platelet-Rich Gel Supernatants.
Gels
June 2024
Grupo de Investigación Patología Clínica Veterinaria, Departamento de Salud Animal, Universidad de Caldas, Calle 65 No 26-10, Manizales 170004, Colombia.
(1) Background: There is a lack of knowledge about how a single dose of COX-2 selective non-steroidal anti-inflammatory drugs (NSAIDs) might affect the release of growth factors (GFs) and cytokines from canine platelet-rich gels (PRGs) and other hemocomponents. (2) Methods: A crossover study was conducted in six adult mongrel dogs. Animals were randomized to receive a single dose of either carprofen or firocoxib.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!